U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Name Type Language
OLVIMULOGENE NANIVACIREPVEC
INN  
Official Name English
GL-ONC1
Preferred Name English
Olvimulogene nanivacirepvec [WHO-DD]
Common Name English
DNA (RECOMBINANT VACCINIA VIRUS STRAIN LIVP CLONE GL-ONC1)
Common Name English
GLV-1H68
Common Name English
DNA (synthetic vaccinia virus oncolytic-strain GLV-1h68 (complete genome))
Common Name English
OLVIMULOGENE NANIVACIREPVEC [USAN]
Common Name English
olvimulogene nanivacirepvec [INN]
Common Name English
RECOMBINANT REPLICATION-COMPETENT ONCOLYTIC VACCINIA VIRUS VACV (LIVP STRAIN) COMPRISING INSERTION OF THE RUC-GFP, BETA-GALACTOSIDASE (LACZ) AND BETA-BLUCURONIDASE (GUSA) REPORTER GENES INTO THE F14.5L, J2R (THYMIDINE KINASE) AND A56R (HEMAGGLUTININ) LOC
Common Name English
Code System Code Type Description
NCI_THESAURUS
C79833
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
INN
11165
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
SMS_ID
300000024156
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
FDA UNII
CF19SF72O5
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
CAS
1473430-36-2
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
USAN
FG-145
Created by admin on Wed Apr 02 05:34:20 GMT 2025 , Edited by admin on Wed Apr 02 05:34:20 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966